Abstract
This open study of alaproclate points towards an antidepressant effect in a relatively chronic and drug-resistant group of depressives. Five patients had an average improvement of more than 21 points on the Hamilton Rating Scale for Depression and six had an average improvement of seven points. Several patients had anticholinergic side effects, abnormal results in liver functional tests and faecal occult blood, but none were bad enough to require being taken off the drug and most side effects improved before the end of the trial.
The biochemical results suggested that the responders and non-responders constituted two distinct biological groups. In the patients who responded well to treatment there were increases in K m values consistent with treatment. The K m and 5-HT values correlated strongly with plasma drug values. There was a strong correlation between Hamilton Rating scores in the 4th week and K m values in the 4th week, although there were only five cases. However, there were no significant relationships between improvement and any pretreatment value.
These results are sufficiently promising to suggest that a controlled clinical trial would yield information on alaproclate as a therapeutic aid.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cleary P, Guy W (1977) Factor Analysis of Hamilton Depression Scale. Drugs and Experimental Clinical Research 1:115–120
Coppen A, Swade C, Wood K (1978) Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin Chim Acta 87:165–168
Coppen A, Rama Rao A, Swade C, Wood K (1979) Inhibition of 5-hydroxytryptamine reuptake by amitriptyline and zimelidine and its relation to their therapeutic action. Psychopharmacology 63:125–129
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Clin Soc Psychol 6:278–296
Lindberg UH, Thorberg S-O, Bengtsson S, Renyi AL, Ross SB, Ogren S-O (1978) Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alphaamino acid esters of phenethyl alcohols. J Med Chem 21:448–456
Lindgren JE (1979) Determination of alaproclate in plasma by mass fragmentography. Internal Astra Report No. 805-07 A 27
Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 34:773–782
Wing JK, Nixon J, Von Granach M, Strauss S (1977) Further developments of the PSE and CATEGO system. Arch Psychiat Neurol Sci 224:151–160
Yuwiler A, Plotkins S, Geller G, Ritvo ER (1970) A rapid accurate procedure for the determination of serotonin in whole human blood. Biochem Med 3:426–436
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frost, S.J., Eccleston, D., Marshall, E.F. et al. Alaproclate — an open clinical study in depressive illness. Psychopharmacology 83, 285–287 (1984). https://doi.org/10.1007/BF00464796
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00464796